Premier Inc., a renowned healthcare improvement firm running one of the biggest group purchasing organisations in the country, has awarded a group purchasing deal to Ritedose, a 503B outsourcing plant in South Carolina (GPOs). With effect from January 1, 2023, the new arrangement enables Premier members to choose whether to […]
Featured News
Abbott Receives Approval From Anvisa For Ultreon™, Imaging Technology That Uses Artificial Intelligence For Coronary Arteries
The National Health Surveillance Agency (Anvisa) recently gave its latest optical coherence tomography (OCT) imaging platform with the new UltreonTM Software its seal of approval, according to Abbott. In order to give clinicians an expanded, comprehensive image of coronary blood flow and blockages to support clinical decision-making and provide the […]
Launch of the CE-IVD-Marked HIV-1 Treatment-Resistant Strain Assay by Thermo Fisher Scientific
Thermo Fisher Scientific, a global leader in providing scientific services, today announced the release of its CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay that analyses HIV-positive samples to find genetic variants that may resist conventional antiretroviral therapies. The test’s results can be used to […]
Sun Pharma intends to acquire Concert Pharmaceuticals to advance potential treatment for alopecia areata
Sun Pharmaceutical Industries Limited and Concert Pharmaceuticals, Inc. declared today that they have signed a legally binding agreement under which Sun Pharma will tender all of Concert’s outstanding shares for an initial cash payment of $8.00 per common share, or $576 million in net worth, in exchange for Concert’s outstanding […]
An ASICS study shows that physical activity has the power to sharpen even the brightest minds and improve mental performance
According to ASICS, exercise has a considerable positive impact on cognitive function and enhances mental ability. Exercise enhances brain power and may be just what we need to ace tests or succeed at work by improving short-term memory and focus levels. In the first trial of its sort, ASICS asked […]
ShiftMed Announces Technology Partnership with UKG to Further Streamline Scheduling and Drive Down Operational Costs for Healthcare Facilities
In order to further streamline scheduling and reduce operational costs for healthcare facilities, ShiftMed and UKG have announced a technology partnership ShiftMed, the first on-demand workforce platform that offers scalable, affordable, and sustainable labour across the full spectrum of care settings—from health system acute and outpatient settings to post-acute and […]
Missing Data From Rapid MRI Scans is Reconstructed by Artificial Intelligence
Artificial Intelligence Reconstructs Missing Data From Rapid MRI Scans According to a recent study by the NYU Grossman School of Medicine and Meta AI Research, artificial intelligence (AI) is capable of reconstructing rapidly performed, coarsely sampled magnetic resonance imaging (MRI) scans into high-quality images with comparable diagnostic value as those […]
Merck Selects Perceiv AI for Inaugural Digital Sciences Studio Cohort
Perceiv AI declared that Merck had chosen it and eight other early-stage biomedical businesses from a pool of 152 applications for the first cohort of the Merck Digital Sciences Studio (MDSS). The program was launched in November to support cutting-edge digital technology for drug research. “Being selected for the Merck […]
Amcor Expands Healthcare Platform In The Asia Pacific Region With Acquisition Of MDK
Amcor, a pioneer in responsible packaging solutions development and production, announced today that it has reached an agreement to buy Shanghai-based MDK. MDK, a market leader in medical device packaging and a key priority growth area for Amcor, has annual sales of about $50 million. Amcor’s existing portfolio is enhanced […]
Bioarctic’s Partner Eisai Submits Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer’s Disease In Japan
A marketing authorization application for lecanemab, an investigational anti-amyloid beta (A) protofibril antibody, has been submitted by BioArctic AB’s (publ) partner Eisai to the Pharmaceuticals and Medical Devices Agency for the treatment of mild cognitive impairment (MCI) brought on by Alzheimer’s disease (AD) and mild Alzheimer’s dementia (collectively known as […]
